{"nct_id":"NCT03154827","title":"Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML)","status":"TERMINATED","status_verified_date":"2024-08","start_date":"2018-01-08","start_date_type":"ACTUAL","primary_completion_date":"2020-04-01","primary_completion_date_type":"ACTUAL","completion_date":"2020-04-01","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["BLRX"]}